2022 -2024 Director- Pharmaceutical Policy and HTA @
2021 -2022 Manager - Policy and Program Development @
2020 -2021 Formulary Management Officer @
2019 -2021 Director, Health Economics and Reimbursement @
2017 -2019 Government Affairs - Ontario @
2015 -2017 Director, Health Economics and Reimbursement @
2012 -2015 Manager, Health Economics and Reimbursement @
2011 -2012 Manager, Health Technology Assessment Analytics @
2011 -2011 Market Access and Pricing Associate Co-op @
2010 -2010 Government and Economic Affairs Associate Co-op @ Eli Lilly and Company
Peter Dyrda Education
McMaster University
MBA (Healthcare Services Management)
2009-2011
McMaster University
B.Sc (Biology & Pharmacology Co-op)
2004-2009
Maastricht University
Doctor of Philosophy - PhD (Health Economics & Policy)
2022
Peter Dyrda Skills
Outcomes Research
Market Access
Health Technology Assessment (HTA)
Health Policy
Health Outcomes
Healthcare
Pharmacoeconomics
Lobbying
Government Relations
Health Economics
HTA
Pharmaceutical Industry
Strategy
Microsoft Excel
Data Analysis
Microsoft Office
Leadership
Program Management
Analytics
Peter Dyrda Summary
Peter Dyrda, is currently a Director, Pharmaceutical Reviews at Canada's Drug Agency. Peter Dyrda brings experience from previous roles at CADTH and The Janssen Pharmaceutical Companies of Johnson & Johnson. Peter Dyrda holds a 2009 - 2011 MBA in Healthcare Services Management @ McMaster University. With a robust skill set that includes Outcomes Research, Market Access, Health Technology Assessment (HTA), Health Policy, Health Outcomes and more. Peter Dyrda has 2 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.